• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events
MEDICAL MARIJUANA

Newsbrief: Few seniors discuss cannabis use with doctors, study

doctors

istockphoto.com

By Alex Halperin
06/04/2026 05:41 PM GMT-0700
FacebookTweetPin

Fewer than one in five seniors who use cannabis discussed it with their doctors according to a new study in the American Journal of Preventative Medicine. Just over 10% of adults over 65 report using cannabis in the last year.

Using nationally representative data derived from more than 14,000 older adults, researchers at Rutgers Health analyzed reports of cannabis and other drug use, whether patients were screened and whether they discussed it with doctors.

“Cannabis use is on . . .

Log in or become a WeedWeek Member to read this article.

Share:
FacebookTweetPin
Filed Under:
Medical Marijuana

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: The Accounts Receivable Crisis

Duration Broadcast May 14th
Speakers Adam Stettner, Brett Gelfand, Alex Halperin

WATCH NOW

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Medical Marijuana Articles
lawmakers
Gavin Newsom

Newsbrief: Newsom’s MED bill veto sparks anger

The Promise of Ketamine as a Rapid-Acting Antidepressant
Sponsored

The Promise of Ketamine as a Rapid-Acting Antidepressant

Former TMS CEO joins Beyond Marketing as Medical and Education Director
Sponsored

Former TMS CEO joins Beyond Marketing as Medical and Education Director

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved